A new initiative announced by the National Institutes of Health (HNIH), backed by a $1.5 billion investment from federal stimulus funding, aims to speed innovation, development, and commercialization of COVID-19 testing technologies. Dubbed the Rapid Acceleration of Diagnostics (RADx) initiative the new program will infuse funding into early innovative technologies to speed development of rapid and widely accessible COVID-19 testing.

HPNE Secures $15 Million BARDA Grant To Expand Manufacturing of Single-Use Solutions
https://www.youtube.com/watch?v=RfMBT0s2G6Y Smithfield, RI – High Purity New England, a supplier of solutions and equipment for the biopharmaceutical industry, announced that they have received a $15M USD contract from the Biomedical Advanced Research and...